Single-cell RNA Sequencing to Identify Cellular Heterogeneity and Targets in Cardiovascular Diseases: from Bench to Bedside
Overview
Affiliations
The mechanisms of cardiovascular diseases (CVDs) remain incompletely elucidated. Single-cell RNA sequencing (scRNA-seq) has enabled the profiling of single-cell transcriptomes at unprecedented resolution and throughput, which is critical for deciphering cardiovascular cellular heterogeneity and underlying disease mechanisms, thereby facilitating the development of therapeutic strategies. In this review, we summarize cellular heterogeneity in cardiovascular homeostasis and diseases as well as the discovery of potential disease targets based on scRNA-seq, and yield new insights into the promise of scRNA-seq technology in precision medicine and clinical application.
Application of Spatial Omics in the Cardiovascular System.
Hu Y, Jia H, Cui H, Song J Research (Wash D C). 2025; 8:0628.
PMID: 40062231 PMC: 11889335. DOI: 10.34133/research.0628.
Lanzer J, Wienecke L, Ramirez Flores R, Zylla M, Kley C, Hartmann N Basic Res Cardiol. 2024; 119(6):1001-1028.
PMID: 39311911 PMC: 11628589. DOI: 10.1007/s00395-024-01074-w.
VICTOR: Validation and inspection of cell type annotation through optimal regression.
Chang C, Hsu C, Liu Q, Shyr Y Comput Struct Biotechnol J. 2024; 23:3270-3280.
PMID: 39296808 PMC: 11408377. DOI: 10.1016/j.csbj.2024.08.028.
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression.
Jiang Z, Kang Q, Qian H, Xu Z, Tong H, Yang J Signal Transduct Target Ther. 2024; 9(1):193.
PMID: 39090109 PMC: 11294589. DOI: 10.1038/s41392-024-01912-2.
OmicVerse: a framework for bridging and deepening insights across bulk and single-cell sequencing.
Zeng Z, Ma Y, Hu L, Tan B, Liu P, Wang Y Nat Commun. 2024; 15(1):5983.
PMID: 39013860 PMC: 11252408. DOI: 10.1038/s41467-024-50194-3.